| 영문 | edema | 한글 | 부종 |
|---|---|---|---|
| 설명 | 조직내에 림프액이나 조직의 삼출물 등의 액체가 저류되어서 과잉 존재하는 상태를 말한다. 이런 현상은 생기는 부위에 따라 피하부종, 폐부종, 복수라 하며, 발생 기전에 따라 분류하면 울혈성 부종, 염증성 부종, 혈관운동성 부종, 기아성 부종, 콩팥탓 부종 등으로 분류된다. 울혈성 부종은 기능성 부종이라고도 하며, 정맥이나 림프관의 협착, 폐쇄로 인하여 정상적인 흐름이 방해받았을 때에 발생하는 것이다. 염증성 부종은 염증성 변화로 인해서 혈관의 투과성이 항진되어 혈관속에 있는 수분이 많이 조직으로 빠져 나가서 생기는 부종이고, 혈관운동성 부종은 혈관운동신경 마비로 유발되며, 기아성 부종은 만성적으로 영양이 부족한 경우에 생기는 부종이다. 콩팥탓 부종은 콩팥병이 있는 경우에 소변으로 영양분이 빠져나가는 경우에 유발된다. 부종은 생기는 부위에 따라 다소 차이가 있을지라도 발생기전에서는 서로 밀접한 관련을 맺고 있으므로 근본적인 원인을 찾아내어 치료를 시작하는 것이 바람직하다. |
||
| HPE | hepatic portoenterostomy; high-permeability edema; history and physical examination; holoprosencepha... |
|---|---|
| Tc cell | cytotoxic T cell |
| ACS | acrocallosal syndrome; acrocephalosyndactyly; acute chest syndrome; acute confusional state; Alcon C... |
| CA | anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can... |
| CI | cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar... |
| BE | Brain edema |
|---|---|
| CSME | Clinically significant macular edema |
| CME | Cystoid macular edema |
| EPH | Edema Proteinuria Hypertension |
| HANE | Hereditary Angio Neurotic Edema |
| edema | <clinical sign> The presence of abnormally large amounts of fluid in the intercellular tissue spaces of the body, usually applied to demonstrable accumulation of excessive fluid in the subcutaneous tissues. Oedema may be localised, due to venous or lymphatic obstruction or to increased vascular permeability or it may be systemic due to heart failure or renal disease. Collections of oedema fluid are designated according to the site, for example ascites (peritoneal cavity), hydrothorax (pleural cavity) and hydropericardium (pericardial sac). Massive generalised oedema is called anasarca. Origin: Gr. Oide ma = swelling (18 Nov 1997) |
|---|---|
| edema, cardiac | A manifestation of congestive heart failure caused by increased venous and capillary pressures and often associated with the retention of sodium by the kidneys. (12 Dec 1998) |
| antireticular cytotoxic serum | An antiserum specific for cells of the reticuloendothelial system. (05 Mar 2000) |
| cytotoxic | <pharmacology> Chemicals that are directly toxic to cells, preventing their reproduction or growth. Cytotoxic agents can, as a side effect, damage healthy, noncancerous tissues or organs which have a high proportion of actively dividing cells, for example, bone marrow, hair follicles. These side effects limit the amount and frequency of drug administration. (16 Dec 1997) |
| cytotoxic cell | Cells of the immune system that inhibit or help to terminate an immune response, e.g., suppressor macrophages and suppressor T-cells. Synonym: cytotoxic cell. (05 Mar 2000) |
| cytotoxic drugs | <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells. See: chemotherapy. (13 Nov 1997) |
| cytotoxic reaction | An immunologic (allergic) reaction in which noncytotropic IgG or IgM antibody combines with specific antigen on cell surfaces; the resulting complex initiates the activation of complement which causes cell lysis or other damage, or which, in the absence of complement, may lead to phagocytosis or may enhance T lymphocyte involvement. (05 Mar 2000) |
| cytotoxic T-cell | <haematology, immunology> Subset of T lymphocytes (mostly CD8) responsible for lysing target cells and for killing virus infected cells (in the context of Class I histocompatibility antigens). (18 Nov 1997) |
| cytotoxic t-lymphocyte | A type of CD8 or, less often, CD4 lymphocyte that kills diseased cells infected by a specific virus or other intracellular microbe. CTLs interact with MHC class I receptors (see Major Histocompatibility Complex). On infected cells and have the prime role in cellmediated immunity (see). Cytovene: See: Ganciclovir. (09 Oct 1997) |
| cytotoxic T lymphocyte-specific serine protease | <enzyme> Structural sequence given in first source Registry number: EC 3.4.21.- Synonym: cytotoxic t lymphocyte-specific serine protease ccp I, cytotoxic t lymphocyte specific serine protease ccp II, mast cell protease type II (26 Jun 1999) |
| T cytotoxic cells | Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their fc receptors. (12 Dec 1998) |
| T-lymphocytes, cytotoxic | Immunised T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (mlc), in vivo during a graft-versus-host (gvh) reaction, or after immunization with an allograft, tumour cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (cml). These cells are distinct from natural killer cells (killer cells, natural) and from killer cells mediating antibody-dependent cell cytotoxicity. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|